Cargando…

Inflammatory Markers in Dysmenorrhea and Therapeutic Options

Dysmenorrhea often significantly reduces the quality of women’s life and is still an important public health problem. Despite numerous studies, the pathomechanism of dysmenorrhea is not fully understood. Previous research indicates the complexity of biochemical reactions between the endocrine, vascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcikowska, Zofia, Rajkowska-Labon, Elżbieta, Grzybowska, Magdalena Emilia, Hansdorfer-Korzon, Rita, Zorena, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068519/
https://www.ncbi.nlm.nih.gov/pubmed/32069859
http://dx.doi.org/10.3390/ijerph17041191
_version_ 1783505598778703872
author Barcikowska, Zofia
Rajkowska-Labon, Elżbieta
Grzybowska, Magdalena Emilia
Hansdorfer-Korzon, Rita
Zorena, Katarzyna
author_facet Barcikowska, Zofia
Rajkowska-Labon, Elżbieta
Grzybowska, Magdalena Emilia
Hansdorfer-Korzon, Rita
Zorena, Katarzyna
author_sort Barcikowska, Zofia
collection PubMed
description Dysmenorrhea often significantly reduces the quality of women’s life and is still an important public health problem. Despite numerous studies, the pathomechanism of dysmenorrhea is not fully understood. Previous research indicates the complexity of biochemical reactions between the endocrine, vascular, and immune systems. Prostaglandins play a major role in the pathomechanism of dysmenorrhea. In contrast, cytokines and other proinflammatory factors in primary dysmenorrhea are less studied. In addition to the applied pharmacotherapy, more and more studies proving the effectiveness of non-pharmacological methods appear. Therefore, the present work contains a review of the latest research concerning factors involved in dysmenorrhea, as well as therapeutic options. In the literature search, authors used online databases, PubMed, and clinitrials.gov and browsed through individual gynecology, physiotherapy journals and books.
format Online
Article
Text
id pubmed-7068519
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70685192020-03-19 Inflammatory Markers in Dysmenorrhea and Therapeutic Options Barcikowska, Zofia Rajkowska-Labon, Elżbieta Grzybowska, Magdalena Emilia Hansdorfer-Korzon, Rita Zorena, Katarzyna Int J Environ Res Public Health Review Dysmenorrhea often significantly reduces the quality of women’s life and is still an important public health problem. Despite numerous studies, the pathomechanism of dysmenorrhea is not fully understood. Previous research indicates the complexity of biochemical reactions between the endocrine, vascular, and immune systems. Prostaglandins play a major role in the pathomechanism of dysmenorrhea. In contrast, cytokines and other proinflammatory factors in primary dysmenorrhea are less studied. In addition to the applied pharmacotherapy, more and more studies proving the effectiveness of non-pharmacological methods appear. Therefore, the present work contains a review of the latest research concerning factors involved in dysmenorrhea, as well as therapeutic options. In the literature search, authors used online databases, PubMed, and clinitrials.gov and browsed through individual gynecology, physiotherapy journals and books. MDPI 2020-02-13 2020-02 /pmc/articles/PMC7068519/ /pubmed/32069859 http://dx.doi.org/10.3390/ijerph17041191 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Barcikowska, Zofia
Rajkowska-Labon, Elżbieta
Grzybowska, Magdalena Emilia
Hansdorfer-Korzon, Rita
Zorena, Katarzyna
Inflammatory Markers in Dysmenorrhea and Therapeutic Options
title Inflammatory Markers in Dysmenorrhea and Therapeutic Options
title_full Inflammatory Markers in Dysmenorrhea and Therapeutic Options
title_fullStr Inflammatory Markers in Dysmenorrhea and Therapeutic Options
title_full_unstemmed Inflammatory Markers in Dysmenorrhea and Therapeutic Options
title_short Inflammatory Markers in Dysmenorrhea and Therapeutic Options
title_sort inflammatory markers in dysmenorrhea and therapeutic options
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068519/
https://www.ncbi.nlm.nih.gov/pubmed/32069859
http://dx.doi.org/10.3390/ijerph17041191
work_keys_str_mv AT barcikowskazofia inflammatorymarkersindysmenorrheaandtherapeuticoptions
AT rajkowskalabonelzbieta inflammatorymarkersindysmenorrheaandtherapeuticoptions
AT grzybowskamagdalenaemilia inflammatorymarkersindysmenorrheaandtherapeuticoptions
AT hansdorferkorzonrita inflammatorymarkersindysmenorrheaandtherapeuticoptions
AT zorenakatarzyna inflammatorymarkersindysmenorrheaandtherapeuticoptions